{
    "success": true,
    "data": {
        "leverage": true,
        "derivates": true,
        "swaps": true,
        "inverse": true,
        "replication_method": "synthetic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Inverse Strategy",
            "Significant Leverage (-3x)",
            "Compounding Effect due to daily rebalancing",
            "Synthetic Replication using derivatives (implied swaps/futures)",
            "Product explicitly targets sophisticated investors due to complexity",
            "KID includes a comprehension alert ('not simple and may be difficult to understand')",
            "Introduces counterparty and collateral risk (inherent to synthetic replication)"
        ],
        "classification": "complex",
        "supporting_data": "The ETP Securities are explicitly identified as 'Collateralised Exchange Traded Securities' and their objective is to provide '-3 times the value of the daily performance' of an underlying fund. This highly leveraged and inverse strategy inherently requires the integral use of derivatives (e.g., swaps or futures) for synthetic replication, rather than just for efficient portfolio management. The KID explicitly highlights the 'Compounding Effect', stating that holding the ETP for more than one day is 'likely to result in a return which is different to -3 times the return of the Reference Asset over that holding period', making its payoff difficult to understand for an average retail investor. The product's own Key Information Document (KID) includes a 'You are about to purchase a product that is not simple and may be difficult to understand' comprehension alert, which is a mandatory requirement for complex products under MiFID II. Furthermore, the KID states the product is intended for 'sophisticated investors' who 'understand the risk of compounded returns and the increased risk of investment in inverse leveraged products', directly acknowledging its complexity and the advanced knowledge required. The underlying assets being held in a 'Margin Account' and the payment obligations funded by 'liquidating the Collateral Assets' also strongly indicate a synthetic structure that exposes investors to counterparty risk and collateral management nuances. While the issuer is regulated by the Central Bank of Ireland, the product type is 'ETP Securities' and is not identified as a UCITS, meaning it does not benefit from the UCITS presumption of non-complexity. Given the significant leverage, inverse objective, reliance on derivatives for its core strategy, compounding effects, and the issuer's own warnings and target investor profile, the ETP clearly meets the criteria for a complex financial instrument under MiFID II and ESMA guidelines (e.g., CESR/09-295 Section V, Art. 38(a) regarding derivatives, and ESMA35-36-1640 Art. 25(4) regarding products difficult to understand)."
    }
}